Fully-automated chip-based nanoelectrospray tandem mass spectrometry of gangliosides from human cerebellum  by Zamfir, Alina et al.
Fully-Automated Chip-Based Nanoelectrospray
Tandem Mass Spectrometry of Gangliosides
from Human Cerebellum
Alina Zamfir, Željka Vukelic´,* Laura Bindila, and Jasna Peter-Katalinic´
Institute for Medical Physics and Biophysics, Biomedical Analysis, University of Münster, Münster, Germany
Reinaldo Almeida, Alistair Sterling, and Mark Allen
Advion BioSciences, Ltd., Norwich, United Kingdom
The introduction of chip-based electrospray (ESI) ion sources into biological mass spectrom-
etry (MS) addressed the fundamental issue of how to analyze minute amounts of complex
biological systems. The automation of sample delivery into the MS combined with the
chip-based ESI allows for high quality bioanalysis in a high-throughput fashion. These
advantages have already been demonstrated in proteomics, direct screening of drugs and drug
discovery. As part of our continuing effort to implement automated chip-based mass
spectrometry into the field of complex carbohydrate analysis, we hereby report the develop-
ment of a chipESI MS and MS/MS methodology for the screening of gangliosides. A strategy
to characterize a complex ganglioside mixture from human cerebellar tissue, by automated
ESIchip-quadrupole time-of-flight (QTOF) MS and MS/MS is presented here. The feasibility of
this method, and the general experimental requirements for automated chipESI MS analysis
of these carbohydrate species is described. (J Am Soc Mass Spectrom 2004, 15, 1649 –1657)
© 2004 American Society for Mass SpectrometryConsiderable efforts are being invested into boththe development of automated and miniaturizedanalytical tools, and their introduction into rou-
tine bioscience [1, 2]. Robotic micro- and nano-systems,
developed for high-throughput accurate analyses, en-
able low sample consumption, by limiting losses
through handling. This can aid considerable in reduc-
ing sample costs and experimental time.
In biological mass spectrometry (MS), the recent
introduction of chip-based electrospray (ESI) ion
sources has enabled the issues of sensitivity in the
analysis of minute amounts of biological materials to be
addressed. These ion sources have also enabled auto-
mated sample delivery into MS instruments, without
risk of cross-contamination, in a high throughput fash-
ion. The advantages of an automated chip-based ESI
infusion have already been widely proven in proteom-
ics, direct screening of drugs and drug discovery [1–7].
Carbohydrates, which are an important and ubiqui-
tous class of biopolymers, have been shown to require
their own particular analytical conditions, for ESI MS
and other related hyphenated techniques. These are
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doi:10.1016/j.jasms.2004.08.002quite distinct to those required by proteins and nucleic
acids [8–16]. Carbohydrates, apart from having a poly-
functional molecular structure consisting of monosac-
charide building blocks, a high diversity and micro-
heterogeneity, also exhibit rather restrictive properties
for ion formation and detection, which are variable
between the different carbohydrate categories. Our
studies are focused on developing new MS strategies to
provide a high throughput and sensitive structural
analysis of complex carbohydrate mixtures, from bio-
logical sources. We have recently described, for the first
time to our knowledge, an automated ESIchip-quadru-
pole time-of-flight (QTOF) MS and tandem MS system
for the screening of complex mixtures of oligosaccha-
rides and glycopeptides. These samples originated from
the urine of patients suffering from Schindler’s disease
or from congenital disorder of glycosylation (CDG) [17].
The chip-based ESI MS methodology has demonstrated
the potential to detect low abundance, known carbohy-
drate species, and novel carbohydrate variants from
heterogeneous glycopeptide mixtures previously only
accessible to structural investigation by combined cap-
illary electrophoresis/mass spectrometry (CE/MS) [18].
Gangliosides, sialylated glycosphingolipids (GSLs),
are composed of mono- to poly-sialylated oligosaccha-
ride chains of variable length, attached to the ceramide
portion, with variable composition with respect to the
types of sphingoid base and fatty acid residues. Gan-
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1650 ZAMFIR ET AL. J Am Soc Mass Spectrom 2004, 15, 1649–1657gliosides are plasma-membrane components, enriched
in the microdomains, particular abundant in the central
nervous system. Here they participate in cell-to-cell
recognition, communication and cell signaling, and are
consequently either modulating or triggering various
biological events [19, 20]. Ganglioside composition is
dependant on both species and cell type. Specific
changes occur during brain development, maturation,
and aging, and due to disease or neurodegeneration
processes [21–23]. They are therefore regarded as tissue
stage- and/or diagnostic markers, and therefore poten-
tially as therapeutic agents. In the human brain, differ-
ences in ganglioside composition, quantity, distribution
and cell surface expression have been shown to have
regional specificity. These differences have been dem-
onstrated by primarily thin-layer chromatography, but
also by immunochemical and immunohistochemical
methods [24, 25].
The cerebellum, a morpho-anatomically and func-
tionally highly specialized region of the brain, has some
characteristic differences in the composition of its major
ganglioside species, when compared to those regions of
the cerebrum that have been studied [22]. The function,
behavior and even survival of cerebellar neurons are
highly dependant on the cellular expression of the
ganglioside species [26].
To analyze complex ganglioside mixtures from bio-
logical sources by MS methods, by either ESI or matrix
assisted laser desorption/ionization (MALDI), specific
ionization conditions are required. These are necessary
to provide a reliable assessment of the sample hetero-
geneity, and to enable identification of the molecular
architecture.
We recently reported an optimized procedure for
()nanoESI-QTOF MS and tandem MS for the charac-
terization of a native ganglioside mixture from brain
tissue [27–30]. This procedure requires elevated param-
eter values for ionization, and an extended time for
MS/MS signal acquisition, which suggests that rela-
tively high sample consumption is needed for identifi-
cation and structural elucidation.
We have also developed an approach that combines
CE for the separation, with a nano ESI-QTOF MS for
detection of single molecular species, and MS/MS for
their identification by sequencing [31]. This approach
allows for a rapid separation procedure followed by
sensitive detection and structural analysis of ganglio-
side/glycosphingolipid species present in complex
mixtures isolated from biological tissues. All MS pa-
rameters were found to require optimization, as they all
had a significant effect on both MS detection and
product ion abundance in fragmentation experiments,
when analyzing single ganglioside molecular species
from CE eluted fractions. Analyte/CE buffer clusters
are optimally decomposed with high capillary and cone
voltages in the ESI ion source. These parameters, at high
values, however can induce in-source fragmentation
jeopardizing the detection of intact molecular ions in
MS1, the selection of precursor ions for fragmentation,and result in a long acquisition time to counterbalance
the in-source decrease in molecular ion abundance. As
part of our effort to implement fully automated chip-
based mass spectrometry in the field of complex carbo-
hydrate analysis, a general methodology for the screen-
ing of glycosphingolipids was initiated. The methods
were optimized with respect to ionization, sensitivity,
automated sequencing, speed of analysis, and limited
sample consumption. The automated ESIchip-QTOF
MS and MS/MS presented here is optimized in nega-
tive ion mode, for the characterization of a complex
ganglioside mixture from human cerebellar tissue. The
data will demonstrate its general utility in ganglioside
analysis, and its advantages when compared to capil-
lary-based ESI MS and MS/MS.
Experimental
Biological Material Sampling and Isolation
of Ganglioside Mixture from Human Cerebellar
Gray Matter
A normal adult human (20 years old) cerebellum,
without any pathological signs according to morpho-
anatomical and histopathological examination, origi-
nated from a healthy subject who died in a traffic
accident. The cerebellum was obtained from the Depart-
ment of Forensic Medicine, Faculty of Medicine, Uni-
versity of Zagreb, Croatia. Permission for experiments
with human tissue for scientific purposes was obtained
from The Ethical Commission of the University of
Zagreb, Croatia, under project no. 108120 by the Min-
istry of Science and Technology of the Republic of
Croatia.
The cerebellar gray matter was carefully separated
from the white matter by dissection. Samples were
weighed and stored at 20 °C until the extraction
procedure. The native mixture of gangliosides was
extracted and purified in our laboratories as described
in detail elsewhere [27]. The sample was dried in a
Speed Vac SPD 111V system (Savant, Düsseldorf, Ger-
many). For ESI MS analysis, a stock solution of the
sample at approximately 1 mg/ml was prepared by
dissolving the dried material in methanol. This stock
solution was stored at 20 °C. Dilution of the stock
solution in pure methanol yielded the working aliquot
concentrations of approximately 15 pmol/l and 2–3
pmol/l. Methanol was obtained from Merck (Darm-
stadt, Germany) and used without further purification.
Distilled and deionized water (Mili-Q Water Systems
Millipore, Bedford, MA) was used for the preparation
of the sample solutions.
Applied Ganglioside Nomenclature
Gangliosides and their precursor glycosphingolipids
are abbreviated according to the system of L. Svenner-
holm, (J. Neurochem. 1963, 10, 613 and Adv. Exp. Med.
Biol. 1980, 125, 11), and the recommendations of the
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(Eur. J. Biochem. 1977, 79, 11 and Eur. J. Biochem. 1998,
257, 293).
Mass Spectrometry
Mass spectrometry was performed on an orthogonal
hybrid quadrupole time-of-flight mass spectrometer
(QTOF Micromass, Manchester, U.K.) in the Micromass
Z-spray geometry. The QTOF mass spectrometer was
interfaced to a PC computer running MassLynx soft-
ware to control the instrument, acquire and process MS
data. The source block temperature was kept at 80 °C.
All mass spectra were acquired in the negative ion
mode, which is known to be advantageous for gangli-
oside MS analysis [27, 30, 32]. Tandem mass spectrom-
etry was carried out by automatic selection and frag-
mentation of the precursor ion with switching from MS
to MS/MS (auto MS/MS) in data-dependant analysis
mode as described by us elsewhere [18]. CID at low
energies was performed using Ar as a collision gas. All
mass spectra were calibrated using sodium iodide as a
calibrant.
Automated Chip-Based Nanoelectrospray
Fully automated chip-based nanoelectrospray was per-
formed on a NanoMate 100 incorporating ESI Chip
technology (Advion BioSciences, Ithaca, NY) mounted
to the QTOF mass spectrometer. The robot was con-
trolled and manipulated by ChipSoft software operat-
ing under Windows. The position of the electrospray
chip was adjusted with respect to the sampling cone to
ensure optimal transfer of the ionic species into the
mass spectrometer. In order to prevent any contamina-
tion, a glass coated microtiter plate was used for all
experiments. 5 l aliquots of the working sample solu-
tions were loaded into a 96-well plate. The robot was
programmed to aspirate the sample, followed by 2 l of
air into the pipette tip, and to deliver the sample to the
inlet side of the microchip. The microchip consists of a
10  10 array of nozzles etched into the planar surface
of a silicon wafer and is fabricated using a variety of
techniques, including deep reactive ion etching. The
preparation of the microchip is described in detail
elsewhere [33]. A channel extends from the nozzle
through the microchip to an inlet on the opposite
surface and during analysis, the conductive pipette tip
containing the sample is engaged against this inlet
forming a pressure seal. Each nozzle has an internal
diameter of 9 m. Electrospray was initiated by apply-
ing voltages between 1.45 to 1.67 kV and a head
pressure of 0.3 to 0.45 p.s.i. Following sample infusion
and MS analysis, the pipette tip was ejected and a fresh
tip and nozzle were used for each sample, thus prevent-
ing any cross-contamination or carry-over.Results and Discussion
Optimization of the Automated Chip-Based
NanoESI-QTOF MS for Ganglioside
Ionization/Detection
The ganglioside sample, G20y, was dissolved in pure
methanol to a final concentration of approximately 15
pmol/l, and transferred into a glass-coated well in the
96-well plate. Chip-based electrospray ionization is initi-
ated with the application of 1.55 kV pipette tip voltage and
0.3 p.s.i. back pressure to the ESI Chip, and 45 V sampling
cone potential. These parameters generate a sustained and
consistent spray, which shows a high ionization yield.
Figure 1a shows the ()nanoESIchip-QTOF mass spec-
trum combined over 1 min of the total ion current (TIC).
Three major ganglioside species are detected here: GM1,
GD1, GT1 containing one, two, and three sialic acid
moieties, respectively, and each exhibiting two different
molecular forms attributable to the fatty acid heterogene-
ity in the ceramide portion. Due to the mild ESI Chip and
sampling cone parameters, certain ions are formed pref-
erentially. These are triply charged ions at m/z 708.68 and
718.00, which correspond to two triply sialylated GT1
molecular species, (d18:1/18:0) and (d18:1/20:0), and
abundant doubly charged ions at m/z 917.37 and 931.39.
These correspond to the disialylated GD1 species, (d18:1/
18:0) and (d18:1/20:0). The GT1 (d18:1/18:0) and (d18:1/
20:0) molecular ions are also observed as intense doubly
charged ions at m/z 1073.84 and 1088.38. The less abun-
dant singly charged ions which correspond to the mono-
sialylated GM1 molecular species (d18:1/18:0) and (d18:
1/20:0) are detected at m/z 1544.47 and 1573.49,
respectively. In addition, singly charged GD1 molecular
ions, at a reduced intensity, are also present in the spec-
trum at m/z 1857.46 and 886.41. These ions are related to
ganglioside species containing the (d18:1/18:0) and (d18:
1/20:0) ceramide residues, respectively. Using the same
G20y sample, independent results have also been ob-
tained by thin-layer chromatography and resorcinol stain-
ing (data not shown). These results indicate that a higher
abundance of GM1 species and a higher degree of heter-
ogeneity than in Figure 1a should be observed. To corre-
late the expression patterns from the TLC to the ionized
species in the mass spectra, the ionization conditions must
be systematically explored. The initial step in the optimi-
zation of the ESI Chip ionization/detection for all the
single ganglioside components in the G20y sample is to
acquire MS data at elevated levels of the ESI Chip and
sampling cone potentials. This approach has already been
demonstrated [30] to enhance the ionization yield of larger
ganglioside species from human brain tissues. In Figure
1b, the nanoESIchip-QTOF mass spectrum recorded for 1
min at 1.67 kV tip potential and 135 V sampling cone
potential is presented. With these parameters a greater
proportion of the GM1 molecules should be ionized and
detected. Indeed GM1 (d18:1/18:0) and (d18:1/20:0) are
detected as abundant singly charged ions at m/z 1544.47
and 1572.51 (Figure 1b). According to our experimental
1652 ZAMFIR ET AL. J Am Soc Mass Spectrom 2004, 15, 1649–1657experience (data not shown) with purified GM1 as well as
GD1 fractions, the intensity of the molecular ion increases
with rising of cone potential. Nevertheless, in the case of
complex mixtures, the ion intensity may be partially
related also to increased in-source fragmentation of more
complex species.
Up to nine ganglioside variants are detected in this
sample under set instrument parameters. Other minor
components and/or longer chains, which are assumed
to be present in the sample, could not, however, be
detected. Of interest is that with the sampling cone
potential of 135 V, the charge distribution did not shift
significantly towards lower values, as expected. In
addition, the signal intensities corresponding to doubly
and triply charged ions were not altered. As already
mentioned, a potential disadvantage of higher voltages
is the in-source fragmentation of ganglioside species. In
the case of ESI Chip, the in-source decay was minimal,
despite the application of a high cone potential. This is
illustrated in Figure 1b, where the signals at m/z 888.54
and 906.61, are only slightly increased. These ions
correspond to GlcCer (d18:1/18:0) in-source fragments.
Earlier work [7] has demonstrated that the NanoMate
ESIchip MS can achieve subpico- and femtomolar levels of
sensitivity in peptide analysis. We have reported results
[17] with the NanoMate ESIchip-QTOF MS, demonstrat-
ing that spectra with a high signal to noise ratio, providing
rich structural information, can be obtained from complex
glycopeptide mixtures, within a few minutes of signal
Figure 1. Fully automated ()nanoESIchip-QT
matter of normal human cerebellum. Sample
assigned (a) sampling cone potential 45 V; acqui
acquisition time 1 min.acquisition. This glycopeptide data was generated fromsamples with a significantly lower concentration of 3
pmol/l.
By diluting the G20y sample serially for the nanoESI-
chip-QTOF MS experiments, the ionization of the gan-
glioside components was significantly enhanced. Figure
2a and b show spectra of the same sample analyzed by
ESIchip-QTOF MS. In these experiments, the conditions
have been modified as detailed below. The sample has
been diluted to 2–3 pmol/l, the ESI tip potential is in-
creased to 1.67 kV, and the sample cone potential is varied
from 45 to 135 V. A fair signal-to-noise ratio is obtained in
less than 1 min, however the mass spectrum is recorded
for 3 min with variable source parameters. This strategy
allows for a high ionization yield, and the detection of a
larger number of species. Using these conditions (Figure
2), a more realistic representation of the ganglioside het-
erogeneity, when compared against the TLC pattern, is
obtained. It is therefore possible to conclude the following:
A well-defined set of experimental conditions allows
ganglioside mixture analysis with a high degree of sensi-
tivity, without compromising the ionization of minor
biologically important components. Furthermore, by the
ESIchip MS approach the in-source decay is avoided, and
the analysis time is reduced significantly.
Table 1 lists the assignment of singly, doubly and triply
charged ions corresponding to 46 different ganglioside
components, which have been identified by automated
chip-based nanoESI-QTOF MS. It is clear that the G20y
ganglioside mixture is dominated by GD1 glycoforms.
S of the G20y ganglioside mixture from gray
entration 15pmol/l in methanol. n.a.  not
time 1 min. (b) sampling cone potential 135 V;OF M
conc
sitionNineteen different doubly charged molecular variants of
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GM1, GM2, GM3, GD2, GD3, GT1, and GQ1, expressing
different ceramide portions.
The most abundant ions are assigned to doubly
charged pseudomolecular species originating from GD1
(d18:1/18:0) and (d18:1/20:0), GT1 (d18:1/18:0) and
(d18:1/20:0) followed by singly charged ions attributed to
GM1 (d18:1/18:0) and (d18:1/20:0). GT1 (d18:1/18:0) and
(d18:1/20:0) molecular species were detected as intense
Figure 2. Fully automated ()nanoESIchip-QTO
pmol/l in methanol; acquisition time 3 min; sa
(a) m/z (700–980). (b) m/z (980–2050).triply charged ions at m/z 708.39 and 717.75 as well.Biologically important O-acetylated and/or fucosy-
lated GM1, GD1, GT1, and GQ1 exhibiting a high degree
of heterogeneity in their ceramide motifs are also detected.
Fucosyl-GD1 (Table 1) has been shown to have the most
glycoforms, and these six fucosylated variants have all
been detected as fairly abundant doubly charged ions.
The triply charged ions at m/z 722.39 and 731.74 are
assigned to O-Ac-GT1 (d18:1/18:0) and O-Ac-GT1 (d18:1/
20:0), respectively, while the doubly charged ions at m/z
S of the G20y mixture. Sample concentration 2–3
ng cone potential 45–135V. n.a.  not assignedF M
mpli1128.92, 1144.89, 1159.89 correspond to Fuc-GT1 (d18:1/
1654 ZAMFIR ET AL. J Am Soc Mass Spectrom 2004, 15, 1649–1657Table 1. Composition of single components in the G20y ganglioside mixture from gray matter of normal human cerebellum as
detected by a fully automated ()nanoESIchip-QTOF MS
Type of molecular ion
m/z (monoisotopic)
Assigned structureDetected Calculated
[M  2Na  4H]2 611.40 611.35 GM3 (d18:1/18:0)
[M  H] 1179.57 1179.74
[M  H] 1382.60 1382.82 GM2 (d18:1/18:0)
[M  2H]2 734.96 734.91 GD3 (d18:1/18:0)
[M  Na  2H] 1492.78 1492.81
[M  2H]2 748.99 748.93 GD3 (d18:1/20:0)
[M  H] 1518.51 1518.85 GM1, nLM1 and /or LM1 (d18:0/16:0)
[M  2H]2 771.98 771.93 GM1, nLM1 and /or LM1 (d18:1/18:0)
[M  H] 1544.61 1544.85
[M  2H]2 786.00 785.92 GM1, nLM1 and /or LM1 (d18:1/20:0)
[M  H] 1572.61 1572.85
[M  H] 1690.55 1690.93 Fuc-GM1(d18:1/18:0)
[M  H] 1716.56 1716.94 Fuc-GM1 (d18:1/20:1)
[M  2H]2 836.46 836.45 GD2 (d18:1/18:0)
[M  2H]2 850.47 850.47 GD2 (d18:1/20:0)
[M  2H]2 917.44 917.48 GD1, nLD1 and /or LD1 (d18:1/18:0)
[M  Na  3H]2 928.45 928.47
[M  H] 1835.62 1835.96
[M  Na  2H] 1857.56 1857.95
[M  2H]2 926.44 926.48 GD1, nLD1 and /or LD1 (t18:0/18:0)
[M  2H]2 924.44 924.49 GD1, nLD1 and /or LD1 (d18:1/19:0)
[M  2H]2 931.46 931.49 GD1, nLD1 and /or LD1 (d18:1/20:0)
[M  Na  3H]2 942.44 942.48
[M  H] 1885.60 1885.98
[M  2H]2 940.49 940.50 GD1, nLD1 and /or LD1 (t18:0/20:0)
[M  2H]2 938.44 938.50 GD1, nLD1 and /or LD1 (d18:1/21:0)
[M  2H]2 945.47 945.51 GD1, nLD1 and /or LD1 (d18:1/22:0)
[M  2H]2 954.46 954.51 GD1, nLD1 and /or LD1 (t18:0/22:0)
[M  2H]2 952.47 952.52 GD1, nLD1 and /or LD1 (d18:1/23:0)
[M  2H]2 958.46* 958.52 GD1, nLD1 and /or LD1 (d18:1/24:1)
[M  2H]2 966.44 966.53 GD1, nLD1 and /or LD1 (d18:1/25:0) or (d20:1/23:0)
[M  2H]2 988.40 988.49 Fuc-GD1 (d18:1/18:2)
[M  2H]2 990.40 990.51 Fuc-GD1 (d18:1/18:0)
[M  2H]2 999.41* 999.51 Fuc-GD1 (t18:0/18:0)
[M  2H]2 1002.41 1002.51 Fuc-GD1 (d18:1/20:2)
[M  2H]2 1004.42 1004.52 Fuc-GD1 (d18:1/20:0)
[M  2H]2 1013.44* 1013.53 Fuc-GD1 (t18:0/20:0)
[M  2H]2 1018.99 1019.02 GalNAc-GD1 (d18:1/18:0)
[M  2H]2 1032.93* 1033.03 GalNAc-GD1 (d18:1/20:0)
[M  3H]3 708.39 708.35 GT1 (d18:1/18:0)
[M  2H]2 1062.96 1063.03
[M  Na  3H]2 1073.96 1074.02
[M  2Na  4H]2 1084.93 1085.01
[M  3H]3 714.41 714.35 GT1 (t18:0/18:0)
[M  Na  3H]2 1082.92 1083.02
[M  3H]3 717.75 717.69 GT1 (d18:1/20:0)
[M  2H]2 1076.97 1077.04
[M  Na  3H]2 1087.95 1088.03
[M  2Na  4H]2 1098.92 1099.02
[M  3H]3 723.75 723.70 GT1 (t18:0/20:0)
[M  Na  3H]2 1096.93 1097.04
[M  Na  3H]2 1094.95* 1095.04 GT1 (d18:1/21:0)
[M  3H]3 727.11 727.04 GT1 (d18:1/22:0)
[M  Na  3H]2 1101.92 1102.05
[M  Na  3H]2 1108.92* 1109.06 GT1 (d18:1/23:0)
[M  Na  3H]2 1114.96 1115.06 GT1 (d18:1/24:1)
[M  3H]3 722.39 722.35 O-Ac-GT1 (d18:1/18:0)
[M  3H]3 731.74 731.70 O-Ac-GT1 (d18:1/20:0)
2[M  2H] 1128.95 1129.05 Fuc-GT1 (d18:1/17:0)
tensi
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Three extended ganglioside structures attributed to GQ1
are detected as triply and doubly charged ions. The triply
charged ion at m/z 819.38 accompanied by its sodiated
form at m/z 826.73 is assigned to O-acetylated GQ1 (d18:
1/18:0) form (Table 1).
Automated Chip-Based NanoESI-QTOF MS/MS
in Data-Dependant Acquisition for Ganglioside
Fragmentation
To investigate the possibility of performing rapid and
accurate ganglioside sequencing, by the automated MS to
MS/MS switching function available on the QTOF mass
Table 1. (continued)
Type of molecular ion
m/z (monoisotopic)
Detected Calcula
[M  2H]2 1144.89 1145.
[M  2H]2 1159.89 1159.
[M  3H]3 805.40 805.
[M  Na  4H]3 812.73 812.
[M  2Na  4H]2 1230.43 1230.
[M  3Na  5H]2 1241.43 1241.
[M  3H]3 814.74 814.
[M  Na  4H]3 822.07 822.
[M  2Na  4H]2 1244.42 1244.
[M  3H]3 819.38* 819.
[M  Na  4H]3 826.73* 826.
d  dihydroxy sphingoid base; t  trihydroxy sphingoid base; * low in
The monoisotopic m/z values of ions are given.
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Figure 3. Automated ()nanoESIchip-QTOF a
charged ion at m/z 709.03; cone potential 135
Assignment of fragment ions is according to Domonspectrometer, the triply charged ion at m/z 708.39 was
selected. This ion is assigned to GT1 (d18:1/18:0). In
data-dependant acquisition (DDA), the automated precur-
sor ion selection is set in the “included masses only”
option. The specific NanoMate parameters are set in
ChipSoft, at 1.67 kV for the nanoESI voltage and 0.45 p.s.i.
nitrogen head pressure. The QTOF MassLynx parameters
are set at 135 V for the sampling cone, with 50 eV collision
energy during the MS/MS scanning. Figure 3 shows the
automated MS/MS data between 280–1600 m/z of the
triply charged ion m/z 709.03, which corresponds to GT1
(d18:1/18:0). In our previous work on ganglioside frag-
mentation by capillary-based ()nanoESI-QTOF, with
manual selection for MS/MS, an extended signal acquisi-
Assigned structure
Fuc-GT1 (t18:0/18:0)
Fuc-GT1 (t18:0/20:0)
GQ1 (d18:1/18:0)
GQ1 (d18:1/20:0)
O-Ac-GQ1 (d18:1/18:0)
ty ions
1000 1100 1200 1300 1400 1500 1600
53
5
1545.65
49
1544.68
17
1253.72
5
1025.67
1546.63
 1547.60
1548.80
5α/B2β -CO2
C
5α/B2β +28
Y
2β and/or Y4α/B1β
Y
2ß 
and/or Y
4α/B1ß
1-
1-
1-
S/MS of the GT1 species detected as a triply
llision energy 50 eV; acquisition time 1 min.ted
06
08
38
71
56
55
72
05
57
38
7100
06
2
918.
918.9
 919.
 920.
951.7
.53
C
2-
uto M
V; coand Costello [34]. n.a.  not assigned.
1656 ZAMFIR ET AL. J Am Soc Mass Spectrom 2004, 15, 1649–1657tion time, with a sample consumption of about 50 pmol,
was necessary. This was because longer time was required
to obtain sufficient diagnostic fragment ions for the struc-
tural assignment of GT1 from a purified fraction [30]. In
the current study with the nanoESIchip and automatic
fragmentation, within 1 min of acquiring MS/MS data,
approximately 0.5 pmol of material were sprayed. When
examined, with respect to the acquisition time, sample
complexity, and sample consumption, the MS/MS spec-
trum has a fair signal-to-noise ratio. It also has a sufficient
set of “fingerprint” ions for the structural elucidation of
the molecule. Abundant GD1 and GM1 fragment ions,
which correspond to successive desialylation of the GT1
precursor ion are observed at m/z 917.53 (doubly charged)
and at m/z 1544.68 (singly charged), as Y-type ions. The
GD1 fragment ion is accompanied by its B1 and C1
counterparts. They are observed as singly charged ions at
m/z 290.20 and 308.23, respectively. The GM1 fragment ion
is accompanied by the singly charged afferent B2 counter-
part at m/z 581.40, assigned to NeuAc2
. Cleavage of the
ceramide moiety forms the singly charged Y0 ion at m/z
564.75, and a singly charged Z0 ion at m/z 546.50. These
fragment ions, in conjunction with the singly charged ion
at m/z 726.70 (GlcCer) and m/z 888.76 (GalGlcCer) are
indicative of the presence of the (d18:1/18:0) ceramide
residue. Additional supporting information for this frag-
mentation pathway depicted in Scheme 1 is provided by
the monosialo fragment ions at m/z 470.25 and m/z 835.21,
and the GalGalNAc ion at m/z 364.36.
Conclusions
This study was designed to assess the potential use of
the fully automated ()nanoESIchip-QTOF MS and
automated MS/MS for the screening and sequencing of
this particular glycoconjugate category. The ganglio-
sides are known to require specific conditions for ion-
ization and detection, fragmentation in tandem MS
experiments at low energies. This automated nanoESI-
chip-QTOF MS methodology, optimized for ganglio-
side analysis, has provided new insights into their
7
581
888
NeuA
NeuAc
NeuAc
Gal GalNAc Gal
290/308
470 835290/308
Scheme 1. Fragmentation pathway by autoMS
ion at m/z 709.03. The structure depicted refers
[27, 30].structural diversity, and complex molecular architec-ture. The approach was applied in the analysis of a
native mixture of gangliosides, extracted from human
cerebellar gray matter. The sample concentration and
instrument parameters were revised, in consideration
of the particular requirements of the chip-based electro-
spray ionization process. When compared with capil-
lary-based ESI MS, chip-based ESI MS had greater
sensitivity, and gave a clearer representation of the
sample composition. NanoESIchip MS screening en-
abled the identification of 46 glycoforms, with a high
degree of heterogeneity in the ceramide motifs and
biologically relevant modifications. When fully auto-
mated chipESI MS infusion was combined with auto-
mated precursor ion selection and fragmentation, a
complete structural data set was obtained for single
ganglioside species from a native mixture of great
complexity. The data was achieved with a short analysis
time, and with drastically reduced sample consump-
tion. The fully automated chip-based ()nanoESI MS
approach described here is of general applicability in
ganglioside analysis, and represents a step forward in
the implementation of automated chipMS methods in
glycomics.
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